跳至主要内容
临床试验/CTRI/2025/02/079934
CTRI/2025/02/079934已完成3 期

Assessing the Effect of Exogenous Melatonin on The Stability of Orthodontic Mini-Implants: A Randomized Controlled Clinical Trial

Sanjai J1 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2025年12月2日最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
20
试验地点
1
主要终点
Implant stability will be evaluated using insertion torque and resonance frequency analysis as primary outcome

研究概览

简要总结

AIM:

The study aims to evaluate the effect of topical administration of melatonin on the stability of orthodontic mini-implants through a Randomized controlled clinical trial.

Research question:

Does the topical administration of melatonin have any effect on the stability of orthodontic mini-implants?

Hypothesis:

The topical administration of melatonin has a significant effect on the stability of orthodontic mini-implants.

The topical administration of melatonin significantly reduces implant migration in orthodontic mini-implants.

The topical administration of melatonin has a significant impact on reducing pain perception during treatment with orthodontic mini-implants.

Null Hypothesis:

The topical administration of melatonin does not have a significant effect on the stability of orthodontic mini-implants.

The topical administration of melatonin does not significantly reduce implant migration in orthodontic mini-implants.

The topical administration of melatonin does not have a significant impact on reducing pain perception during treatment with orthodontic mini-implants.

P: Patients with average growth patterns, class I bimaxillary cases with upper first premolar extraction.

I: Topical melatonin application over the mini implant.

C: Placebo application over the mini implant.

O: Implant stability, Implant migration, and pain perception.

S: The sample size is 20

Experimental Group: Topical melatonin administration + mini-implant

Control Group: Placebo (matching appearance) + mini-implant

Based on the inclusion and exclusion criteria the Orthodontic patients requiring mini-implants for anchorage support will be selected in this study.

The primary objective is to evaluate implant stability through insertion torque and resonance frequency analysis. The secondary outcomes include assessing implant migration and pain perception among participants.

Throughout the treatment period, patients will undergo orthodontic procedures, including bracket placement and wire adjustments. TADs will be inserted and data collected at specific intervals.

Data collected will be tabulated and statistically analyzed.

This study holds a non-invasive adjunctive approach to optimize mini-implant stability and treatment outcomes. If proven effective, exogenous melatonin could become a valuable addition to the orthodontic armamentarium, by enhancing anchorage support.

研究设计

研究类型
Interventional
分配方式
Computer generated randomization
盲法
Participant and Outcome Assessor Blinded

入排标准

年龄范围
15.00 Year(s) 至 25.00 Year(s)(—)
性别
All

入选标准

  • •Patients requiring orthodontic treatment involving the placement of mini implants for anchorage support.
  • •Patients with average growth patterns, class I bimaxillary cases with upper first premolar extraction, and space closure will be selected to standardize the cases.
  • •Young adults aged 15-25 years old will be selected.

排除标准

  • •Patients with known sleep cycle disturbances, metabolic bone disorders to melatonin will be excluded.
  • •Pregnant or lactating individuals, as melatonin administration may affect pregnancy outcomes or breast milk composition.
  • •Patients who have used melatonin supplements 3 months before the study Patients with active ongoing orthodontic treatment with Poor oral hygiene will be excluded which will lead to implant failure.
  • •Patients unable or unwilling to attend scheduled follow-up visits will be excluded.

结局指标

主要结局

Implant stability will be evaluated using insertion torque and resonance frequency analysis as primary outcome

时间窗: insertion torque value measured at the time of insertion and Resonance Frequency Analysis (RFA) measurements will be taken | At the time of mini-implant placement(T1), | One month after mini-implant placement as (T2), | Two months after mini-implant placement (T3), | Three months after mini-implant placement (T4

次要结局

  • The implant migration and pain perception will be evaluated as secondary outcome(Implant migration data will be collected from the lateral cephalogram)

研究者

发起方
Sanjai J
申办方类型
Other [self]

研究点 (1)

Loading locations...

相似试验